Target intelligence / Profile preview

Gastric mucosal surface

Molecular classification
Other
01

Overview

The **gastric mucosal surface** forms the innermost layer of the stomach, defined by a single layer of columnar surface mucous (foveolar) cells that secrete alkaline mucus enriched with bicarbonate. This surface creates a critical barrier, protecting the underlying tissue from autodigestion by gastric acid and digestive enzymes. It participates in mucosal repair via cell turnover and restitution but does not represent a single druggable molecular target. The disruption of this barrier, as can occur with NSAID use or *Helicobacter pylori* infection, is a central mechanism in peptic ulcer and gastritis pathology. Therapy focuses on protecting or restoring barrier function, rather than directly modulating a single molecular target. The "gastric mucosal surface" is best described as a protective anatomical region, not as a molecular drug target or receptor. Dose- or drug-response relationships, as for specific enzymes or receptors, do not apply.

Other names
Gastric surfaceStomach mucosal surfaceGastric surface epitheliumFoveolar surface
02

Mechanism of action

Enhance mucosal protection (mucosal protectants increase mucus/bicarbonate) Reduce acid damage (antacids, PPIs diminish acid exposure) Promote mucosal healing (some drugs enhance restitution and cytoprotection)

03

Biological functions

Protective barrier against gastric acid and digestive enzymesLubrication of food and mucosal surfaceFacilitating mucosal repair and restitution
04

Disease associations

Ulcer formation (when barrier is compromised)GastritisHelicobacter pylori infectionOther gastric injury/inflammation states
05

Safety considerations

Breakdown leads to ulcers, bleeding, and potentially perforationImpaired barrier increases infection and injury risksRestoration can be slow in elderly or malnourished patients
06

Interacting drugs

Antacids

4 more in the full profile.

07

Biomarkers

*Helicobacter pylori* detection (for infectious cause of mucosal injury)Occult blood (for ulcer detection)Null for molecular biomarkers specific to the “gastric mucosal surface”

Beyond the preview

Go deeper on Gastric mucosal surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastric mucosal surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call